Search results for: Japan
Filter search results
HTA in Japan: Failing to Meet International Good Practice?
15 March 2019
The Japanese government has recently announced new plans to implement HTA from April 2019. The ISPOR HTA Task Force published ‘Good Practices in HTA’ in January 2019. The Japanese proposals…
Data Governance Arrangements for Real-world Evidence in Japan
12 September 2019
…briefly introduces the Japanese health system before presenting in more detail the arrangements behind the collection and management of patient data. In Japan, as well as other countries, academic studies…
Price Comparisons of Identical Products in Japan, the United States and Europe
1 August 1981
…US both are approximately half the levels prevailing in Japan. The significance of this for the future of Japan’s progress in pharmaceutical innovation and its eventual penetration of world pharmaceutical…
Data Governance Arrangements for Real-World Evidence in Japan
1 September 2019
…method and structure as the original2. This third report focuses on data governance arrangements for RWE in Japan. On this occasion, relevant information has been collected by the Japanese authors…
G7 Investments in New Antibiotics Would Pay Off – For Everyone
9 December 2022
…is planning a scale-up, while programs to incentivise antibiotic research and development (R&D) are under consideration in the United States (US), European Union (EU), Canada, and Japan. A few weeks…
New Paper in Quality of Life Research – Can Patients’ Self-Reported Pain be Compared and Aggregated in Multi-Country Studies?
30 March 2017
…Japan and Spain) on the EQ-5D. Existing data sets were used to explore differences in responses on the EQ-5D descriptive system between Japan (3L and 5L), the UK (3L), England…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
Most countries regulate manufacturer prices for pharmaceuticals, either directly (France, Italy) or indirectly through controls on reimbursement (Germany, Japan) or profits (the UK). It is widely believed that drug prices…
The broader economic benefits of COVID-19 vaccination
13 October 2025
…due to COVID-19 are about twice as high as healthcare system costs in Australia and Japan, seven times larger in the UK, and ten times larger in the Netherlands. Investing…
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
18 September 2023
…Excellence (NICE) decision outcomes on healthcare decision-making in 12 countries across the globe (Australia, Brazil, Canada, France, Italy, Israel, Japan, South Korea, Poland, Saudi Arabia, Sweden, and the United Arab…